预测芬兰青光眼药物补偿的趋势:2070年更新的系统动态模型
Eemil Lehtonen1, Anja Tuulonen2, Sanna Leinonen1,2
1Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
BMJ open ophthalmology
|August 24, 2025
概括
由于人口老龄化, 到2070年芬兰的眼光障碍药物使用量将增加57%. 这项研究更新了预测模型,预测未来对眼治疗的需求,强调了适应性资源分配的必要性.
科学领域:
- 眼科和公共卫生
- 视力障碍的流行病学
- 卫生经济学和资源分配
背景情况:
- 眼病是不可逆转的失明的主要原因, 随着全球人口老龄化,
- 准确预测青光眼药物的使用对于有效的医疗保健规划和资源分配至关重要.
- 之前的模型需要更新以反映当前的人口趋势,并预测未来对眼治疗的需求.
研究的目的:
- 评估2004年系统动态 (SD) 模型的准确性,以预测芬兰的青光眼药物使用者.
- 更新SD模型以1990-2023年的数据来预测到2070年的药物使用者.
- 评估最近净增长放缓的趋势是暂时的还是持续的.
主要方法:
- 从芬兰社会保险机构获得的关于获得补偿的青光眼药物使用者的数据 (1986-2023年).
- 将芬兰人口预测 (2021-2070年),人口变化,死亡率和移民纳入更新的SD模型.
- 根据观察到的趋势验证预测,并使用专家共识进行参数化.
主要成果:
- 更新后的模型预测到2070年,青光眼药物使用者的数量将增加57% (151,846人),主要是由于75岁以上人口的增长.
- 该模型准确地反映了2015年至2023年期间用户净增长的放缓.
- 预计2033年至2048年经济增长将同样放缓,然后再加快.
结论:
- 到2070年,芬兰对眼治疗的需求增加需要积极的资源配置和持续监测.
- 需求的暂时波动凸显了眼科护理的适应性预测方法的需要.
- 更新的模型提供了一个监测青光眼护理趋势和国家医疗资源分配的框架.
关键词:
青光眼相关概念视频
Glaucoma: Overview
749
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
749
Open Angle Glaucoma: Treatment
561
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
561
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
224
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
224


